Cited by 1,521Cancer-related Molecular PathwaysHeat shock proteins researchPI3K/AKT/mTOR signaling in cancer

The DOI matches its Crossref record; 65 of the 72 references it cites were found in a registry or an index.

The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2’s inhibition of p53

Open access

Pomerantz, Jason, Schreiber-Agus, Nicole, Liégeois, Nanette J, Silverman, Adam, Alland, Leila, Chin, Lynda, Potes, Jason, Chen, Ken, Orlow, Irene, Lee, Han-Woong, Cordon-Cardo, Carlos, DePinho, Ronald A·1998·Cell

DOI 10.1016/s0092-8674(00)81400-2

Open this paper in CoChat — free account Open PDF

Abstract

The INK4a gene encodes two distinct growth inhibitors--the cyclin-dependent kinase inhibitor p16Ink4a, which is a component of the Rb pathway, and the tumor suppressor p19Arf, which has been functionally linked to p53. Here we show that p19Arf potently suppresses oncogenic transformation in primary cells and that this function is abrogated when p53 is neutralized by viral oncoproteins and dominant-negative mutants but not by the p53 antagonist MDM2. This finding, coupled with the observations that p19Arf and MDM2 physically interact and that p19Rrf blocks MDM2-induced p53 degradation and transactivational silencing, suggests that p19Arf functions mechanistically to prevent MDM2's neutralization of p53. Together, our findings ascribe INK4a's potent tumor suppressor activity to the cooperative actions of its two protein products and their relation to the two central growth control pathways, Rb and p53.

Integrity signals

Registry

Crossref · 10.1016/s0092-8674(00)81400-2

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Recombinant Genomes Which Express Chloramphenicol Acetyltransferase in Mammalian Cells
Gorman, C., Moffat, L. F., & Howard, B. H. (1982) · Molecular and Cellular Biology · doi:10.1128/mcb.2.9.1044 · Cited by 7,674
Cancer Cell Cycles
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379
The retinoblastoma protein and cell cycle control
Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90385-2 · Cited by 4,862
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
The p53 tumour suppressor gene
Levine, A. J., Momand, J. A., & Finlay, C. A. (1991) · Nature · doi:10.1038/351453a0 · Cited by 3,785
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312

Show all 72 references

Research works printed but not linked: 6

Brenner, 1996, Preferential loss of expression of p16INK4a rather than p19ARF in breast cancer, Clin. Cancer Res., 2, 1993
Elledge, 1996, A question of balance, Trends Biochem. Sci., 6, 388
Kinoshita, 1996, Altered p16INK4 and retinoblastoma protein status in non-small cell lung cancer, Cancer Res., 56, 5557
Quelle, 1995, Cloning and characterization of murine p16INK4a and p15INK4b genes, Oncogene, 11, 635
Schreiber-Agus, 1994, Evolutionary relationships and functional conservation among vertebrate Max-associated proteins, Oncogene, 9, 3167
Schreiber-Agus, 1997, An amino-terminal domain of Mxi1 mediates anti-Myc oncogenic activity and interacts with a homolog of the yeast transcriptional repressor SIN3, Cell, 80, 777, 10.1016/0092-8674(95)90356-9 · DOI

Sorted by citations

Items 301–400 of 1,001

The Oscar-worthy role of Myc in apoptosis
Meyer, N., Kim, S. S., & Penn, L. Z. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.07.011 · Cited by 132
Dysregulation of cellular signaling by HER2 in breast cancer
Zhou, B. P. (2003) · Seminars in Oncology · doi:10.1053/j.seminoncol.2003.08.006 · Cited by 127
Interaction Between Poor Glycemic Control and 9p21 Locus on Risk of Coronary Artery Disease in Type 2 Diabetes
Doria, A. (2008) · JAMA · doi:10.1001/jama.2008.649 · Cited by 127
Mitochondrial p32 Is a Critical Mediator of ARF-Induced Apoptosis
Itahana, K., & Zhang, Y. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.04.002 · Cited by 126
Level of retinoblastoma protein expression correlates with p16 (MTS-1/INK4A/CDKN2) status in bladder cancer
Benedict, W. F., Lerner, S. P., Zhou, J., Shen, X., Tokunaga, H., & Czerniak, B. A. (1999) · Oncogene · doi:10.1038/sj.onc.1202452 · Cited by 126
Classic and novel roles of p53: prospects for anticancer therapy
Fuster, J. J., Sanz-Gonzalez, S. M., Moll, U. M., & Andrés, V. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.03.002 · Cited by 128
Adenovirus-Mediated p14ARF Gene Transfer in Human Mesothelioma Cells
Yang, C., You, L., Yeh, C., Chang, J. W. C., Zhang, F., McCormick, F. P., & Jablons, D. M. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.8.636 · Cited by 126
Into the heart: The emerging role of the ubiquitin–proteasome system
Willis, M. S., & Patterson, C. (2006) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2006.07.015 · Cited by 125
PML interaction with p53 and its role in apoptosis and replicative senescence
Pearson, M. A., & Pelicci, P. G. (2001) · Oncogene · doi:10.1038/sj.onc.1204856 · Cited by 126
Induction of p21 WAF1/CIP1 and Inhibition of Cdk2 Mediated by the Tumor Suppressor p16 INK4a
Mitra, J., Dai, C. Y., Somasundaram, K., El‐Deiry, W. S., Satyamoorthy, K., Herlyn, M., & Enders, G. H. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3916 · Cited by 125
Modeling mutations in the G1 arrest pathway in human gliomas: overexpression of CDK4 but not loss of INK4a–ARF induces hyperploidy in cultured mouse astrocytesPreprint
Holland, E. C., Hively, W. P., Gallo, V., & VARMUS, H. E. (1998) · Genes & Development · doi:10.1101/gad.12.23.3644 · Cited by 124
Ubiquitin‐mediated control of oncogene and tumor suppressor gene products
Kitagawa, K., Kotake, Y., & Kitagawa, M. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01196.x · Cited by 127
Association of MC1R Variants and Host Phenotypes With Melanoma Risk in CDKN2A Mutation Carriers: A GenoMEL Study
Démenais, F., Mohamdi, H., Chaudru, V., Goldstein, A. M., Newton‐Bishop, J., Bishop, D. T., Kanetsky, P. A., Hayward, N. K., Gillanders, E. M., Elder, D. E., et al. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq363 · Cited by 123
p16/Cyclin-Dependent Kinase Inhibitor 2A Deficiency in Human Melanocyte Senescence, Apoptosis, and Immortalization: Possible Implications for Melanoma Progression
Sviderskaya, E. V., Gray‐Schopfer, V. C., Hill, S. P., Smit, N. P. M., Evans-Whipp, T. J., BOND, J. A., Hill, L., Bataille, V. A., Peters, G., Kipling, D., et al. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.10.723 · Cited by 131
Regulation of MDMX nuclear import and degradation by Chk2 and 14-3-3
LeBron, C., Chen, L., Gilkes, D. M., & Chen, J. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601032 · Cited by 122
Egr1 mediates p53-independent c-Myc–induced apoptosis via a noncanonical ARF-dependent transcriptional mechanism
Boone, D. N., Qi, Y., Li, Z., & Hann, S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008848108 · Cited by 122
Regulation of the MDM2-p53 Pathway by Ribosomal Protein L11 Involves a Post-ubiquitination Mechanism
Dai, M., Shi, D., Jin, Y., Sun, X., Zhang, Y., Grossman, S. R., & Lu, H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602596200 · Cited by 124
DNA damage and cell cycle checkpoints in hyperoxic lung injury: braking to facilitate repair
O’Reilly, M. A. (2001) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2001.281.2.l291 · Cited by 122
Defining the molecular basis of Arf and Hdm2 interactions
Bothner, B. B., Lewis, W. S., DiGiammarino, E. L., Weber, J. D., Bothner, S. J., & Kriwacki, R. W. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.5110 · Cited by 122
Regulation of BRCA1 Expression by the Rb-E2F Pathway
Wang, A., Schneider‐Broussard, R., Kumar, A. P., MacLeod, M. C., & Johnson, D. G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.6.4532 · Cited by 122
Keeping an old friend under control: regulation of p53 stability
Kubbutat, M. H. G., & Vousden, K. H. (1998) · Molecular Medicine Today · doi:10.1016/s1357-4310(98)01260-x · Cited by 122
Frequent Abnormalities of the P15 and P16 Genes in Mycosis Fungoides and Sezary Syndrome
Scarisbrick, J. J., Woolford, A. J. ‐., Calonje, E. J., Photiou, A., Ferreira, S., Orchard, G. E., Russell‐Jones, R., & Whittaker, S. J. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2001.01682.x · Cited by 121
E2F transcriptional repressor complexes are critical downstream targets of p19ARF/p53-induced proliferative arrest
Rowland, B. D., Denissov, S. G., Douma, S., Stunnenberg, H. G., Bernards, R., & Peeper, D. S. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00085-5 · Cited by 120
p53-Dependent Translational Control of Senescence and Transformation via 4E-BPs
Petroulakis, E., Parsyan, A. E., Dowling, R. J. O., Bacquer, O. L., Martineau, Y., Bidinosti, M., Larsson, O. S., Alain, T., Rong, L., Mamane, Y., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.09.025 · Cited by 122
CDKN2A Alterations and Response to Immunotherapy in Solid Tumors
Adib, E., Nassar, A. H., Akl, E. W., Alaiwi, S. A., Nuzzo, P. V., Mouhieddine, T. H., Sonpavde, G., Haddad, R. I., Mouw, K. W., Giannakis, M., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-0575 · Cited by 124
CDK4 gene amplification in osteosarcoma: Reciprocal relationship withINK4A gene alterations and mapping of 12q13 amplicons
Guo, W., Lonardo, F., Ueda, T., Kim, T. K., Huvos, A. G., Healey, J. H., & Ladanyi, M. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990118)80:2 · Cited by 125
INK4a gene expression and methylation in primary breast cancer: overexpression of p16INK4a messenger RNA is a marker of poor prognosis.
Hui, R., Macmillan, R. D., Kenny, F. S., Musgrove, E. A., Blamey, R. W., Nicholson, R. I., Robertson, J. F. R., & Sutherland, R. L. (2000) · PubMed · Cited by 120
The antiangiogenic agent TNP-470 requires p53 and p21 CIP/WAF for endothelial cell growth arrest
Yeh, J.-R. J., Mohan, R., & Crews, C. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.23.12782 · Cited by 120
Pathway analysis of senescence-associated miRNA targets reveals common processes to different senescence induction mechanisms
Lafferty‐Whyte, K., Cairney, C. J., Jamieson, N. B., Oien, K. A., & Keith, W. N. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.02.003 · Cited by 120
Multiple Stress Signals Activate Mutant p53 In Vivo
Suh, Y., Post, S. M., Elizondo-Fraire, A. C., Macció, D. R., Jackson, J. G., El‐Naggar, A. K., Pelt, C. V., Terzian, T., & Lozano, G. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0459 · Cited by 119
The Arf tumor suppressor gene promotes hyaloid vascular regression during mouse eye development
McKeller, R. N., Fowler, J. L., Cunningham, J. J., Warner, N., Smeyne, R. J., Zindy, F., & Skapek, S. X. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052484199 · Cited by 120
Ubiquitin-dependent Degradation of p73 Is Inhibited by PML
Bernassola, F., Salomoni, P., Oberst, A., Como, C. J. D., Pagano, M., Melino, G., & Pandolfi, P. P. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031943 · Cited by 118
AML1-ETO rapidly induces acute myeloblastic leukemia in cooperation with the Wilms tumor gene, WT1
Nishida, S., Hosen, N., Shirakata, T., Kanato, K., Yanagihara, M., Nakatsuka, S., Hoshida, Y., Nakazawa, T., Harada, Y., Tatsumi, N., et al. (2005) · Blood · doi:10.1182/blood-2005-04-1656 · Cited by 118
Loss of the ARF tumor suppressor reverses premature replicative arrest but not radiation hypersensitivity arising from disabled atm function.
Kamijo, T., van de Kamp, E. H., Chong, M. J., Zindy, F., Diehl, J. A., Sherr, C. J., & McKinnon, P. J. (1999) · PubMed · Cited by 117
Oncolytic activity of the E1B-55 kDa-deleted adenovirus ONYX-015 is independent of cellular p53 status in human malignant glioma xenografts.
Geoerger, B., Grill, J., Opolon, P., Morizet, J., Aubert, G., Terrier‐Lacombe, M., Paillerets, B. B., Barrois, M., Feunteun, J., Kirn, D. H., et al. (2002) · PubMed · Cited by 117
Neurotransmitter receptor activation triggers p27Kip1 and p21CIP1 accumulation and G1 cell cycle arrest in oligodendrocyte progenitors
Ghiani, C. A., Eisen, A. M., Yuan, X. Q., DePinho, R. A., McBain, C. J., & Gallo, V. (1999) · Development · doi:10.1242/dev.126.5.1077 · Cited by 117
Self-citation
Genomic alterations in spontaneous and carcinogen-induced murine melanoma cell lines
Melnikova, V. O., Bolshakov, S. V., Walker, C., & Ananthaswamy, H. N. (2004) · Oncogene · doi:10.1038/sj.onc.1207405 · Cited by 118
The Paradoxical Role of Cellular Senescence in Cancer
Yang, J., Liu, M., Hong, D., Zeng, M., & Zhang, X. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.722205 · Cited by 125
Adenovirus and cell cycle control
Ben-Israel, H. (2002) · Frontiers in bioscience · doi:10.2741/ben · Cited by 117
Phenotype vs Genotype in the Evolution of Astrocytic Brain Tumors
Kleihues, P., & Ohgaki, H. (2000) · Toxicologic Pathology · doi:10.1177/019262330002800121 · Cited by 115
Cutaneous melanoma susceptibility and progression genes
DESNOO, F., & Hayward, N. K. (2005) · Cancer Letters · doi:10.1016/j.canlet.2004.12.033 · Cited by 117
Expression and Significance of p53, Rb, p21/waf-1, p16/ink-4a, and PTEN Tumor Suppressors in Canine Melanoma
Koenig, A., Bianco, S. R., Fosmire, S. P., Wojcieszyn, J. W., & Modiano, J. F. (2002) · Veterinary Pathology · doi:10.1354/vp.39-4-458 · Cited by 114
Epstein-Barr Virus Nuclear Antigen 3C Augments Mdm2-Mediated p53 Ubiquitination and Degradation by Deubiquitinating Mdm2
Saha, A., Murakami, M., Kumar, P., Bajaj, B. G., Sims, K., & Robertson, E. S. (2009) · Journal of Virology · doi:10.1128/jvi.02408-08 · Cited by 120
The genetics of transitional cell carcinoma: progress and potential clinical application
Knowles, M. A. (1999) · British Journal of Urology · doi:10.1046/j.1464-410x.1999.00217.x · Cited by 114
Regulation of the p53 protein by the MDM2 oncoprotein--thirty-eighth G.H.A. Clowes Memorial Award Lecture.
Freedman, D. A., & Levine, A. J. (1999) · PubMed · Cited by 114
Tissue-specific alternative splicing in the human INK4a/ARF cell cycle regulatory locus
Robertson, K. D., & Jones, P. A. (1999) · Oncogene · doi:10.1038/sj.onc.1202737 · Cited by 115
Mutations in the INK4a/ARF Melanoma Susceptibility Locus Functionally Impair p14ARF
Rizos, H., Darmanian, A., Holland, E. A., Mann, G. J., & Kefford, R. F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105299200 · Cited by 113
Activation of p53 by oncogenes.
Lowe, S. W. (1999) · Endocrine Related Cancer · doi:10.1677/erc.0.0060045 · Cited by 117
Apoptotic Caspases Regulate Induction of iPSCs from Human Fibroblasts
Li, F., He, Z., Shen, J., Huang, Q., Li, W., Liu, X., He, Y., Wolf, F., & Li, C. (2010) · Cell stem cell · doi:10.1016/j.stem.2010.09.003 · Cited by 115
Inactivation of p21Sensitizes Cells to Apoptosis via an Increase of Both p14ARF and p53 Levels and an Alteration of the Bax/Bcl-2 Ratio
Javelaud, D., & Besançon, F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204497200 · Cited by 112
p53 mediated death of cells overexpressing MDM2 by an inhibitor of MDM2 interaction with p53
Wasylyk, C., Salvi, R., Argentini, M., Dureuil, C., Delumeau, I., Abecassis, J., Debüssche, L., & Wasylyk, B. (1999) · Oncogene · doi:10.1038/sj.onc.1202528 · Cited by 112
The p16INK4a tumour suppressor protein inhibits αvβ3 integrin‐mediated cell spreading on vitronectin by blocking PKC‐dependent localization of αvβ3 to focal contacts
Fåhræus, R., & Lane, D. P. (1999) · The EMBO Journal · doi:10.1093/emboj/18.8.2106 · Cited by 112
Myc-ARF (Alternate Reading Frame) Interaction Inhibits the Functions of Myc
Datta, A., Nag, A., Pan, W., Hay, N., Gartel, A. L., Colamonici, O. R., Mori, Y., & Raychaudhuri, P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312305200 · Cited by 113
Determination of the frequency of the common 657Del5 Nnijmegen breakage syndrome mutation in the German population: No association with risk of breast cancer
Carlomagno, F., Chang-Claude, J. C., Dunning, A. M., & Ponder, B. A. J. (1999) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199908)25:4 · Cited by 48
Novel Function of the Cyclin A Binding Site of E2F in Regulating p53-Induced Apoptosis in Response to DNA Damage
Hsieh, J.-K., Yap, D., O’Connor, D. J., Fogal, V., Fallis, L., Chan, F., Zhong, S., & Lü, X. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.1.78-93.2002 · Cited by 112
p53 pathway dysfunction is highly prevalent in acute myeloid leukemia independent of TP53 mutational status
Quintás‐Cardama, A., Hu, C., Qutub, A. A., Qiu, Y. H., Zhang, X., Post, S. M., Zhang, N., Coombes, K. R., & Kornblau, S. M. (2016) · Leukemia · doi:10.1038/leu.2016.350 · Cited by 116
Inactivation of the p14ARF, p15INK4B and p16INK4A genes is a frequent event in human oral squamous cell carcinomas
Shintani, S., Nakahara, Y., Mihara, M., Ueyama, Y., & Matsumura, T. (2001) · Oral Oncology · doi:10.1016/s1368-8375(00)00142-1 · Cited by 111
Mécanismes moléculaires contrôlant le cycle cellulaire : aspects fondamentaux et implications en cancérologie
Viallard, J.-F., Lacombe, F., Belloc, F., Pellegrin, J., & Reiffers, J. J. (2001) · Cancer/Radiothérapie · doi:10.1016/s1278-3218(01)00087-7 · Cited by 123
E2F1 Induces Phosphorylation of p53 That Is Coincident with p53 Accumulation and Apoptosis
Rogoff, H. A., Pickering, M., Debatis, M. E., Jones, S. N., & Kowalik, T. F. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.15.5308-5318.2002 · Cited by 111
Overexpression of p16 and p14ARF is associated with human papillomavirus infection in cervical squamous cell carcinoma and dysplasia
Sano, T., Masuda, N., Oyama, T., & Nakajima, T. (2002) · Pathology International · doi:10.1046/j.1440-1827.2002.01359.x · Cited by 110
Identification of Three Functions of the Adenovirus E4orf6 Protein That Mediate p53 Degradation by the E4orf6-E1B55K Complex
Querido, E., Morrison, M. R., Dang, H. C. P., Thirlwell, S. W.-L., Boivin, D., & Branton, P. E. (2001) · Journal of Virology · doi:10.1128/jvi.75.2.699-709.2001 · Cited by 110
Frequent p16-Independent Inactivation of p14ARF in Human Melanoma
Freedberg, D. E., Rigas, S. H., Russak, J. E., Gai, W., Kaplow, M., Osman, I., Turner, F., Randerson‐Moor, J. A., Houghton, A. N., BUSAM, K. J., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn157 · Cited by 110
Lens Fibre Cell Differentiation – A Link with Apoptosis?
Dahm, R. (1999) · Ophthalmic Research · doi:10.1159/000055530 · Cited by 110
ARF Function Does Not Require p53 Stabilization or Mdm2 Relocalization
Korgaonkar, C. K., Zhao, L., Modestou, M., & Quelle, D. E. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.1.196-206.2002 · Cited by 111
Telomere dysfunction alters the chemotherapeutic profile of transformed cells
Lee, K.-H., Rudolph, K. L., Ju, Y.-J., Greenberg, R. A., Cannizzaro, L. A., Chin, L., Weiler, S. R., & DePinho, R. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051629198 · Cited by 111
Self-citation
Evaluation of alternative methods of cervical cancer screening for resource-poor settings
Denny, L., Kuhn, L., Pollack, A. E., Wainwright, H., & Wright, T. C. (2000) · Cancer · doi:10.1002/1097-0142(20000815)89:4 · Cited by 250
p53-Dependent and p53-Independent Activation of Autophagy by ARF
Abida, W. M., & Gu, W. J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2069 · Cited by 109
Adenovirus-mediated overexpression of p14ARF induces p53 and Bax-independent apoptosis
Hemmati, P., Gillissen, B. F., von Haefen, C., Wendt, J., Stärck, L., Güner, D., Dörken, B., & Daniel, P. T. (2002) · Oncogene · doi:10.1038/sj.onc.1205458 · Cited by 109
To clear, or not to clear (senescent cells)? That is the question
Lujambio, A. (2016) · BioEssays · doi:10.1002/bies.201670910 · Cited by 108
Differential effects of p19 Arf and p16 Ink4a loss on senescence of murine bone marrow-derived preB cells and macrophages
Randle, D. H., Zindy, F., Sherr, C. J., & Roussel, M. F. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171217498 · Cited by 108
Concomitant expression of p16INK4a and p14ARF in primary breast cancer and analysis of inactivation mechanisms
Silva, J., Silva, J. M., Domínguez, G., García, J. M., Cantos, B., Rodríguez, R., Larrondo, F. J., Provencio, M., España, P., & Bonilla, F. (2003) · The Journal of Pathology · doi:10.1002/path.1297 · Cited by 107
Disruption of the ARF transcriptional activator DMP1 facilitates cell immortalization, Ras transformation, and tumorigenesisPreprint
Inoue, K., Wen, R., Rehg, J. E., Adachi, M., Cleveland, J. L., Roussel, M. F., & Sherr, C. J. (2000) · Genes & Development · doi:10.1101/gad.14.14.1797 · Cited by 107
Cited2 Is an Essential Regulator of Adult Hematopoietic Stem Cells
Kranc, K. R., Schepers, H., Rodrigues, N. P., Bamforth, S. D., Villadsen, E., Ferry, H., Bouriez‐Jones, T., Sigvardsson, M., Bhattacharya, S., Jacobsen, S. E. W., et al. (2009) · Cell stem cell · doi:10.1016/j.stem.2009.11.001 · Cited by 109
Molecular analysis of urothelial cancer cell lines for modeling tumor biology and drug response
Nickerson, M., Witte, N., Im, K. M., Turan, S., Owens, C. R., Misner, K., Tsang, S. X., Cai, Z., Wu, S., Dean, M. C., et al. (2016) · Oncogene · doi:10.1038/onc.2016.172 · Cited by 106
Regulation of p53 - insights into a complex process
Boehme, K. A., & Blattner, C. (2009) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409230903401507 · Cited by 107
DNA Damage Disrupts the p14ARF-B23(Nucleophosmin) Interaction and Triggers a Transient Subnuclear Redistribution of p14ARF
Lee, C., Smith, B. A., Bandyopadhyay, K., & Gjerset, R. A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1759 · Cited by 106
Regulation of Caspase 8- and Caspase 9-Induced Apoptosis by the Herpes Simplex Virus Type 1 Latency-Associated Transcript
Henderson, G., Peng, W., Jin, L., Perng, G., Nesburn, A. B., Wechsler, S. L., & Jones, C. (2002) · Journal of NeuroVirology · doi:10.1080/13550280290101085 · Cited by 106
P16 UV mutations in human skin epithelial tumors
Soufir, N., Molès, J., Vilmer, C., Moch, C., VEROLA, O., Rivet, J., Tesnière, A., Dubertret, L., & Basset‐Séguin, N. (1999) · Oncogene · doi:10.1038/sj.onc.1202915 · Cited by 106
New roles for the RB tumor suppressor protein
Liu, H., Dibling, B. C., Spike, B. T., Dirlam, A., & Macleod, K. F. (2003) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2003.11.005 · Cited by 107
An update on molecular genetics of gastrointestinal stromal tumours
Tornillo, L., & Terracciano, L. (2006) · Journal of Clinical Pathology · doi:10.1136/jcp.2005.031112 · Cited by 105
p14 ARF Activates a Tip60-Dependent and p53-Independent ATM/ATR/CHK Pathway in Response to Genotoxic Stress
Eymin, B., Claverie, P., Salon, C., Leduc, C., Col, E., Brambilla, E. M., Khochbin, S., & Gazzéri, S. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.02240-05 · Cited by 111
Overexpression of the cyclin-dependent kinase inhibitor p16 is associated with tumor recurrence in human prostate cancer.
Ct, L., Capodieci, P., Osman, I., Fazzari, M. J., Ferrara, J., Scher, H. I., & Cordon‐Cardo, C. (1999) · PubMed · Cited by 105
Self-citation
Flavopiridol-induced apoptosis is mediated through up-regulation of E2F1 and repression of Mcl-1.
Ma, Y., Cress, W. D., & Haura, E. B. (2003) · PubMed · Cited by 105
Mdm2 overexpression and p14ARF inactivation are two mutually exclusive events in primary human lung tumors
Eymin, B., Gazzéri, S., Brambilla, C., & Brambilla, E. M. (2002) · Oncogene · doi:10.1038/sj.onc.1205359 · Cited by 104
Development of the Ocular Lens
(2004) · Cambridge University Press eBooks · doi:10.1017/cbo9780511529825 · Cited by 105
Signaling Pathways Activated by Oncogenic Forms of Abl Tyrosine Kinase
Zou, X., & Calame, K. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.26.18141 · Cited by 104
Differential requirement for p19ARF in the p53-dependent arrest induced by DNA damage, microtubule disruption, and ribonucleotide depletion
Khan, S. H., Moritsugu, J., & Wahl, G. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3266 · Cited by 103
Defects in TGFβ signaling overcome senescence of mouse keratinocytes expressing v-rasHa
Tremain, R., Marko, M. G., Vijayachandra, K., Ueno, H., Böttinger, E. P., & Glick, A. B. (2000) · Oncogene · doi:10.1038/sj.onc.1203471 · Cited by 107
Influence of Genes, Nevi, and Sun Sensitivity on Melanoma Risk in a Family Sample Unselected by Family History and in Melanoma-Prone Families
Chaudru, V., Chompret, A., Paillerets, B. B., Spatz, A., Avril, M.-F., & Démenais, F. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh136 · Cited by 103
Concurrent Inactivation of RB1 and TP53 Pathways in Anaplastic Oligodendrogliomas
Watanabe, T., Yokoo, H., Yokoo, M., Yonekawa, Y., Kleihues, P., & Ohgaki, H. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.12.1181 · Cited by 103
ZBP-89 Promotes Growth Arrest through Stabilization of p53
Bai, L., & Merchant, J. L. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.14.4670-4683.2001 · Cited by 103
The DAP kinase family of pro‐apoptotic proteins: novel players in the apoptotic game
Kögel, D., Prehn, J. H. M., & Scheidtmann, K. H. (2001) · BioEssays · doi:10.1002/bies.1050 · Cited by 103
Endoplasmic Reticulum Stress Accelerates p53 Degradation by the Cooperative Actions of Hdm2 and Glycogen Synthase Kinase 3β
Pluquet, O., Qu, L., Baltzis, D., & Koromilas, A. E. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.21.9392-9405.2005 · Cited by 106
Bmi-1, stem cells and cancer
Jiang, L., Li, J., & Song, L. (2009) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmp040 · Cited by 104
Successful growth and characterization of mouse pancreatic ductal cells: functional properties of the Ki-RASG12V oncogene
Schreiber, F. S., Deramaudt, T. B., Brunner, T. B., Boretti, M. I., Gooch, K. J., Stoffers, D. A., Bernhard, E. J., & Rustgi, A. K. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.03.058 · Cited by 104
INK4a/ARFLocus Alterations in Human Non-Hodgkin's Lymphomas Mainly Occur in Tumors with Wild-Type p53 Gene
Pinyol, M., Hernández, L., Martı́nez, A., Cobo, F., Hernandez, S. F., Beà, S., López‐Guillermo, A., Nayach, I., Palacı́n, A., Nadal, A., et al. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65071-7 · Cited by 102
Analysis of the degradation function of Mdm2.
Kubbutat, M. H. G., Ludwig, R., Levine, A. J., & Vousden, K. H. (1999) · PubMed · Cited by 102
SOCS1 regulates senescence and ferroptosis by modulating the expression of p53 target genes
Saint‐Germain, E., Mignacca, L., Vernier, M., Bobbala, D., Ilangumaran, S., & Ferbeyre, G. (2017) · Aging · doi:10.18632/aging.101306 · Cited by 103
Alterations of the p16-pRb Pathway and the Chromosome Locus 9p21–22 in Non-Small-Cell Lung Carcinomas
Gorgoulis, V. G., Zacharatos, P., Kotsinas, A., Liloglou, T., Kyroudi, A., Veslemes, M., Rassidakis, A., Halazonetis, T. D., Field, J. K., & Kittas, C. N. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65690-8 · Cited by 101
DAP Kinase—A Proapoptotic Gene That Functions as a Tumor Suppressor
Raveh, T. B., & Kimchi, A. (2001) · Experimental Cell Research · doi:10.1006/excr.2000.5134 · Cited by 100

Authors: Pomerantz, J., Schreiber-Agus, N., Liégeois, N. J., Silverman, A., Alland, L., Chin, L., Potes, J., Chen, K., Orlow, I., Lee, H.-W., Cordon-Cardo, C., & DePinho, R. A.
Affiliations: Albert Einstein College of Medicine (US)
Memorial Sloan Kettering Cancer Center (US)
Corresponding author: DePinho, Ronald A
ORCID: Pomerantz, Jason
Liégeois, Nanette J
Chen, Ken
Orlow, Irene
Lee, Han-Woong
DePinho, Ronald A
Venue: Cell
Publisher: Elsevier BV
Published: 1998-03
Volume: 92
Issue: 6
Pages: 713-723
ISSN: 0092-8674 (ISSN-L)
DOI: 10.1016/s0092-8674(00)81400-2
OpenAlex: W2039463309
Cited by: 1,521
References: 72
Citations by year: 2026: 4 · 2025: 10 · 2024: 6 · 2023: 23 · 2022: 19 · 2021: 23 · 2020: 19 · 2019: 16 · 2018: 12 · 2017: 24 · 2016: 27 · 2015: 32 · 2014: 44 · 2013: 44 · 2012: 47
FWCI: 64.86
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 5617 d)
Locations: Cell (publishedVersion)
PubMed (publishedVersion)
Funders: National Cancer Institute (CA 47179, CA 47538, CADK97650, P01CA047179)
Topics: Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Keywords: p19ARF, INK4A, MDM2, p53, tumor suppression, protein-protein interaction, p53 degradation, p53 transactivation, oncogenic transformation, Rb pathway, viral oncoproteins, dominant-negative mutant
MeSH terms: Animals, Biotin, Cell Line, Deoxyuracil Nucleotides, Lens, Crystalline, Neoplasm Proteins, Nuclear Proteins, Osteoblasts, Proteins, Proto-Oncogene Proteins, Staining and Labeling, Transformation, Genetic, Tumor Suppressor Protein p53, Retinoblastoma Protein, Apoptosis, Genes, p16, Tumor Suppressor Protein p14ARF, Mice, Proto-Oncogene Proteins c-mdm2, DNA Fragmentation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2’s inhibition of p53

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks